Marshall Wace’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-160,390
| Closed | -$345K | – | 2899 |
|
|
2024
Q3 | $345K | Hold |
160,390
| – | – | ﹤0.01% | 1925 |
|
|
2024
Q2 | $828K | Buy |
160,390
+806
| +0.5% | +$4.16K | ﹤0.01% | 1611 |
|
|
2024
Q1 | $854K | Buy |
159,584
+134,766
| +543% | +$721K | ﹤0.01% | 1501 |
|
|
2023
Q4 | $193K | Buy |
+24,818
| New | +$193K | ﹤0.01% | 1675 |
|
|
2023
Q2 | – | Sell |
-30,551
| Closed | -$81.6K | – | 2626 |
|
|
2023
Q1 | $81.6K | Buy |
+30,551
| New | +$81.6K | ﹤0.01% | 2015 |
|
|
2022
Q2 | – | Sell |
-8,189
| Closed | -$97K | – | 3290 |
|
|
2022
Q1 | $97K | Buy |
+8,189
| New | +$97K | ﹤0.01% | 2475 |
|
|
2021
Q4 | – | Sell |
-18,345
| Closed | -$820K | – | 3679 |
|
|
2021
Q3 | $820K | Sell |
18,345
-11,296
| -38% | -$505K | ﹤0.01% | 1645 |
|
|
2021
Q2 | $1.62M | Buy |
+29,641
| New | +$1.62M | 0.01% | 1219 |
|
|
2021
Q1 | – | Sell |
-4,642
| Closed | -$504K | – | 2603 |
|
|
2020
Q4 | $504K | Buy |
+4,642
| New | +$504K | ﹤0.01% | 1321 |
|
|
2020
Q3 | – | Sell |
-2,446
| Closed | -$261K | – | 1950 |
|
|
2020
Q2 | $261K | Buy |
+2,446
| New | +$261K | ﹤0.01% | 1331 |
|
|
2018
Q2 | – | Sell |
-1,310
| Closed | -$170K | – | 867 |
|
|
2018
Q1 | $170K | Buy |
+1,310
| New | +$170K | 0.01% | 527 |
|